We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,988 hedge funds and large institutions have $199B invested in Johnson & Johnson in 2014 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 785 increasing their positions, 914 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 30

5% more funds holding in top 10

Funds holding in top 10: 688720 (+32)

1% more funds holding

Funds holding: 1,9761,988 (+12)

0% more capital invested

Capital invested by funds: $198B → $199B (+$72M)

0.89% less ownership

Funds ownership: 67%66.11% (-0.89%)

14% less repeat investments, than reductions

Existing positions increased: 785 | Existing positions reduced: 914

27% less call options, than puts

Call options by funds: $1.28B | Put options by funds: $1.76B

Holders
1,988
Holders Change
+12
Holders Change %
+0.61%
% of All Funds
57.66%
Holding in Top 10
720
Holding in Top 10 Change
+32
Holding in Top 10 Change %
+4.65%
% of All Funds
20.88%
New
59
Increased
785
Reduced
914
Closed
30
Calls
$1.28B
Puts
$1.76B
Net Calls
-$484M
Net Calls Change
-$99.2M
Name Holding Trade Value Shares
Change
Change in
Stake
CIBC Asset Management
351
CIBC Asset Management
Ontario, Canada
$37.4M -$945K -9,113 -3%
SBH
352
Segall Bryant & Hamill
Illinois
$36.7M +$540K +5,203 +2%
Susquehanna International Group
353
Susquehanna International Group
Pennsylvania
$36.7M +$3.86M +37,208 +12%
PC
354
Perry Capital
New York
$36.5M
Zurich Cantonal Bank
355
Zurich Cantonal Bank
Switzerland
$36M -$5.74M -55,304 -14%
NSLI
356
Nan Shan Life Insurance
Taiwan
$36M -$3.01M -29,000 -8%
SMDAM
357
Sumitomo Mitsui DS Asset Management
Japan
$35.7M -$1.32M -12,698 -4%
CT
358
Cambridge Trust
Massachusetts
$35.7M +$122K +1,176 +0.4%
KCM
359
Kames Capital Management
United Kingdom
$35.6M +$1.43M +13,809 +4%
NRS
360
Neville Rodie & Shaw
New York
$35.6M +$1.39M +13,355 +4%
BHIA
361
Birch Hill Investment Advisors
Massachusetts
$35.6M -$155K -1,495 -0.4%
SRIM
362
Saratoga Research & Investment Management
California
$35.4M -$1.62M -15,642 -4%
NB
363
Norinchukin Bank
Japan
$35.2M +$746K +7,188 +2%
UCFA
364
United Capital Financial Advisors
Texas
$35.2M +$3.96M +38,150 +13%
PSUF
365
People's United Financial
Connecticut
$35M +$1.95M +18,848 +6%
TCM
366
Tekla Capital Management
Massachusetts
$34.9M +$33.9M +327,212 New
Berkshire Hathaway
367
Berkshire Hathaway
Nebraska
$34.9M
AIM
368
Artemis Investment Management
United Kingdom
$34.7M +$33.7M +325,147 New
First Trust Advisors
369
First Trust Advisors
Illinois
$34M +$5.42M +52,232 +20%
FFA
370
First Foundation Advisors
California
$33.8M +$634K +6,116 +2%
PRA
371
Parametric Risk Advisors
Connecticut
$33.6M
CC
372
Curian Capital
Colorado
$33.3M +$1.12M +10,766 +4%
PGFC
373
Peapack-Gladstone Financial Corp
New Jersey
$33.2M -$254K -2,448 -0.8%
BAM
374
Barrett Asset Management
New York
$33.2M +$64.8K +625 +0.2%
PP
375
Prospector Partners
Connecticut
$33M -$6.18M -59,600 -16%

JNJ Hedge Fund Activity: Q3 2014 in Review

1,988 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2014, worth a combined $199B — up 0.04% from $198B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new JNJ positions and 30 closed out — a net gain of 29 holders — while 785 added to existing stakes and 914 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $544M. The largest seller was Norges Bank, cutting an estimated $2.13B.

  • 1,988 institutional investors held Johnson & Johnson (JNJ) as of Q3 2014, up from 1,976 in Q2 2014.
  • Funds reported $199B of Johnson & Johnson stock for Q3 2014, up 0.04% quarter-over-quarter.
  • 59 funds opened new Johnson & Johnson positions in Q3 2014 and 30 closed out, a net change of +29 holders.
  • The largest Johnson & Johnson buyer in Q3 2014 was Deutsche Bank, an estimated $544M added.
  • The largest Johnson & Johnson seller in Q3 2014 was Norges Bank, an estimated $2.13B sold.

Based on aggregated 13F filings for Q3 2014.